Aberdeen Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $350K | Sell |
14,422
-583
| -4% | -$14.1K | 0.23% | 107 |
|
|
2025
Q1 | $380K | Sell |
15,005
-398
| -3% | -$10.1K | 0.26% | 98 |
|
|
2024
Q4 | $409K | Sell |
15,403
-4,899
| -24% | -$130K | 0.28% | 97 |
|
|
2024
Q3 | $588K | Buy |
20,302
+476
| +2% | +$13.8K | 0.39% | 79 |
|
|
2024
Q2 | $555K | Sell |
19,826
-1,149
| -5% | -$32.1K | 0.38% | 77 |
|
|
2024
Q1 | $582K | Sell |
20,975
-1,726
| -8% | -$47.9K | 0.34% | 78 |
|
|
2023
Q4 | $654K | Sell |
22,701
-291
| -1% | -$8.38K | 0.47% | 64 |
|
|
2023
Q3 | $763K | Buy |
22,992
+1
| +0% | +$33 | 0.57% | 46 |
|
|
2023
Q2 | $843K | Buy |
22,991
+1
| +0% | +$37 | 0.61% | 42 |
|
|
2023
Q1 | $938K | Sell |
22,990
-4,574
| -17% | -$187K | 0.7% | 40 |
|
|
2022
Q4 | $1.41M | Buy |
27,564
+4,576
| +20% | +$234K | 1.07% | 25 |
|
|
2022
Q3 | $1.01M | Sell |
22,988
-59
| -0.3% | -$2.58K | 0.89% | 35 |
|
|
2022
Q2 | $1.21M | Sell |
23,047
-135
| -0.6% | -$7.08K | 0.96% | 30 |
|
|
2022
Q1 | $1.2M | Buy |
23,182
+300
| +1% | +$15.5K | 0.82% | 34 |
|
|
2021
Q4 | $1.35M | Buy |
22,882
+488
| +2% | +$28.8K | 0.88% | 29 |
|
|
2021
Q3 | $963K | Sell |
22,394
-766
| -3% | -$32.9K | 0.93% | 33 |
|
|
2021
Q2 | $907K | Hold |
23,160
| – | – | 0.84% | 39 |
|
|
2021
Q1 | $839K | Sell |
23,160
-389
| -2% | -$14.1K | 0.67% | 46 |
|
|
2020
Q4 | $867K | Sell |
23,549
-71
| -0.3% | -$2.61K | 0.65% | 40 |
|
|
2020
Q3 | $822K | Sell |
23,620
-348
| -1% | -$12.1K | 0.78% | 37 |
|
|
2020
Q2 | $744K | Buy |
23,968
+4,074
| +20% | +$126K | 0.8% | 40 |
|
|
2020
Q1 | $616K | Sell |
19,894
-462
| -2% | -$14.3K | 0.75% | 44 |
|
|
2019
Q4 | $757K | Buy |
+20,356
| New | +$757K | 0.56% | 47 |
|